Fintel reports that on April 28, 2025, Cantor Fitzgerald initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a ...

Viking Therapeutics (VKTX) stock rises as Pfizer (PFE) plans to bolster its pipeline with cardiometabolic and other obesity drugs, through acquisitions. Read more here.

We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at ...

Shares of Viking Therapeutics (NASDAQ: VKTX) jumped 12.5% through 11:40 a.m. ET on Tuesday on further support from Wall ...

Discover why VKTX's deep selloff offers a compelling opportunity with improved safety margins, promising GLP-1 candidates, ...

Viking Therapeutics (NasdaqCM:VKTX) reported a quarterly net loss of $45.63 million for Q1 2025, up from $27.36 million in the previous year, pushing the stock up 7.7% over the last week. Despite the ...

Viking Therapeutics, Inc.’s VKTX share price has surged by 5.65%, which has investors questioning if this is right time to ...

Viking Therapeutics releases its first-quarter results after Wednesday's closing bell. Here's a look at the details from the ...

In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against other takeover rumor stocks hedge funds are buying. Hedge funds tend to pile up on a ...

In a report released today, George Farmer from Scotiabank reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report), with a price ...

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Viking Therapeutics Inc (Symbol: VKTX), where a total volume of 26,955 ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.